Nov 23,2022

Ferrum Health to Offer iCAD's Breast AI Technologies within its Women's Health AI Hub

Ferrum Health, a leader in healthcare enterprise AI solutions, announces an agreement with iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, to offer iCAD's breast AI solutions on Ferrum Health's platform. The onboarding of iCAD's Profound AI® for Digital Breast Tomosynthesis (DBT) and PowerLook® Density Assessment tools expands Ferrum's suite of AI algorithms within its Women's Health AI Hub.

COLLABORATION PARTNERSHIP

#product & service

#ai/software

#platform

View Analyst & Ambassador Comments
Go to original news
Nov 23,2022

Affidea wins "Diagnosis and Primary Care" Award at the prestigious LaingBuisson Health Awards

Affidea, Europe's largest provider of advanced diagnostic, cancer treatment and outpatient services, is pleased to announce that the company has won the LaingBuisson Health "Diagnosis and Primary Care" award from this year.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Nov 27,2022

Personalized breast care advancements from Volpara Health empower providers, patients, and partners at RSNA 2022

Volpara Health Technologies Ltd., a global leader in software for the early detection of cancer, will showcase advancements in personalized breast care at the Annual Radiological Society of North America (RSNA) meeting, November 27 to December 1, 2022 (South Hall, #2772).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Nov 27,2022

Seno Medical's Market-Ready Imagio® OA/US Breast Imaging System Launches at RSNA 2022, Booth 6120

Seno Medical, makers of the Imagio® Breast Imaging System will officially launch the commercially available system at the annual RSNA Scientific Assembly and Annual Meeting starting November 27 through December 1 in Chicago (Booth 6120).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Nov 28,2022

Aidence and Google Health enter into collaboration to help improve lung cancer screening with AI

Aidence and Google Health announce an agreement to license Google Health’s AI research model for lung nodule malignancy prediction on CT imaging. Aidence will develop, validate, and bring this model to the market to support the early and accurate diagnosis of lung cancer and the reduction of unnecessary procedures in screening programmes.

COLLABORATION PARTNERSHIP

#data & technology

#ai/software

View Analyst & Ambassador Comments
Go to original news
Nov 28,2022

Lunit Unveils Real-World Data Backing Clinical Efficacy of AI for the First Time in Breast Cancer Research; Abstracts to be Presented at RSNA 2022

Lunit, a global provider of AI-powered cancer solutions, today announced that it unveiled real-world data (RWD) validating the clinical efficacy of AI in actual medical settings for the first time in the field of breast cancer research at this year's RSNA meeting. The company will be presenting a total of 12 abstracts—8 oral presentations and 4 poster presentations—at the 108th RSNA Annual Meeting to be held from Nov. 27 – Dec. 1.

CONFERENCES

#rwd

#ai/software

View Analyst & Ambassador Comments
Go to original news
Nov 29,2022

OncoHealth to Present at the 2022 San Antonio Breast Cancer Symposium on Off-Label Trastuzumab Deruxtecan and Use in Breast Cancer Brain Metastases

OncoHealth™, a leading digital health company dedicated to oncology, will present the results of its latest real-world data research on trastuzumab deruxtecan (T-DXd) for the treatment of breast cancer on December 8 at the 2022 San Antonio Breast Cancer Symposium (SABCS). Led by Laura R. Bobolts, PharmD, BCOP, Shanthi Marur, MBBS, MD, and Andrew Toler, MS, at OncoHealth, the two poster presentations focus on two aspects of T-DXd, a drug that improves outcomes in HER2-positive and HER2-low metastatic breast cancer (MBC) patients.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Nov 30,2022

Massive Bio Co-Founders To Attend ASH Annual Meeting and Exposition

Massive Bio Co-Founders Selin Kurnaz, PhD, and Arturo Loaiza-Bonilla, MD, will be among the attendees at the 64th ASH Annual Meeting and Exposition, one of the most important events in the field of hematology, which will take place on December 10-13, 2022, in New Orleans, Louisiana.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Nov 30,2022

Volpara Health software used in largest image quality evaluation to date

At the 2022 Radiological Society of North America (RSNA) Annual Meeting, Peter R. Eby, MD, of Virginia Mason Medical Center presented the results of the largest mammographic image quality evaluation to date, titled "Reduction in technical repeat and recall rate after implementation of artificial intelligence driven quality improvement software." This study highlights the potential for AI in revolutionizing what has traditionally been a very manual process, by providing continuous mammography image quality feedback to technologists on an unprecedented scale.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Nov 30,2022

Let's Win Pancreatic Cancer launches an updated platform

Let's Win Pancreatic Cancer is proud to introduce their rethought platform. The new design retains all the robust features patients rely on but makes it easier for website visitors to access the information they need. The streamlined signature flag of the sophisticated new logo reflects their mission to continue to lead the way forward. Let's Win continues to see its role as a partner to the medical community and the voice of the patient.

PRODUCT

#platform

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY